Keep in mind that all three brand name drugs contain the active ingredient semaglutide
But like all medications, side effects are possible when taking GLP-1s
Understanding 'Compounded' Drugs The FDA describes compounding as creating customized medication by mixing or altering ingredients according to an individual patient's needs
In addition to the US FDA approved GLP-1RAs, there are GLP1/glucagon dual agonists (Cotadutide, BI 456906), GIP/GLP1 dual agonists (Tirzepatide, GIP/GLP peptide I and II), GIP/GLP1/glucagon tri-agonists (HM15211, GGG tri-agonist) and GLP1R agonists (Efpeglenatide, Rybelsus) currently in phase 1- III clinical trials for T2D, obesity, and NASH (MASH) treatments (12)
The popularity of semaglutide has grown rapidly in recent years